Marco Schmidt

Member of Drug Development Advisory Board

Marco is Chief Scientific Officer and Co-Founder of AI-enabled causal modelling company, biotx.ai. Prior to his focus on utilising AI technology to enhance clinical research, Marco had an exceptional academic career, winning Best PhD of the year award in Chemistry in his home country Germany before doing a Post-Doc at the University of Cambridge.

During his time at Cambridge, Marco received a Marie-Curie fellowship, as well as a stipend from the Gates Foundation to do his own research. Working with people like Chris Abell and Tom Blundell opened his eyes to the possibilities of launching his own company, as well as to the limitation of traditional approaches to drug development: The inability to predict clinical efficacy. Solving this problem became the mission of biotx.ai.

Get started with us today

Discover what’s possible when you have the right partner. Get in touch to see how we can support you.

Other board members

Got a question? Get in Touch or Submit an RFI/RFP


Our team is on hand to answer any questions you might have relating to the work we do at Simbec-Orion. Just fill in the form below, making sure to tick the boxes that apply, and we’ll respond as quickly as we can.

Looking to volunteer for a clinical trial?

Visit our dedicated volunteer website here, or email [email protected]

Follow us on Social Media

Send us a message, we’ll respond as quickly as possible

Complete the form below, and we’ll get back to you as soon as possible regarding your query.

Name(Required)
Opt In Emails